Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b.
Cameron E SnellMadeline GoughCheng LiuKathryn MiddletonChristopher PykeCatherine ShannonNatasha WoodwardTheresa E HickeyJane E ArmesWayne D TilleyPublished in: British journal of cancer (2018)
This study demonstrates that ER:PR-B interactions have utility in predicting patient response to adjuvant AI therapy.